Shopping Cart
- Remove All
- Your shopping cart is currently empty
GSK321 is a selective and potent mutant isocitrate dehydrogenase 1 (IDH1) inhibitor that inhibits lipid synthesis and blocks cell proliferation in OPA1-deficient MEFs and prevents cytoplasmic glutamine reductive carboxylation.GSK321 has been used in the study of leukemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $160 | In Stock |
Description | GSK321 is a selective and potent mutant isocitrate dehydrogenase 1 (IDH1) inhibitor that inhibits lipid synthesis and blocks cell proliferation in OPA1-deficient MEFs and prevents cytoplasmic glutamine reductive carboxylation.GSK321 has been used in the study of leukemia. |
In vitro | METHODS: R132G IDH1 AML cells were treated with GSK321 (0.01-10 μM) and the intracellular 2-HG level was observed. RESULTS: The intracellular 2-HG level decreased in a concentration-dependent manner, with an inhibition rate of 78% at a GSK321 concentration of 1.7 μM. [1] |
Alias | GSK-321, GSK 321 |
Molecular Weight | 501.55 |
Formula | C28H28FN5O3 |
Cas No. | 1816331-63-1 |
Smiles | C(N1C2=C(C(C(NC3=CC([C@H](C)O)=CC=C3)=O)=N1)CN(C(=O)C4=CC=CN4)C[C@H]2C)C5=CC=C(F)C=C5 |
Relative Density. | 1.35 g/cm3 (Predicted) |
Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (398.76 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.